Hiv care – Wankanyakla Self Help Group Wed, 29 Jun 2022 00:15:00 +0000 en-US hourly 1 Hiv care – Wankanyakla Self Help Group 32 32 Anderson man arrested, charged with not disclosing his HIV status | New Wed, 29 Jun 2022 00:15:00 +0000

ANDERSON — An Anderson man has been arrested on suspicion of failing to report his HIV status to a sexual partner.

According to a probable cause affidavit prepared by Anderson Police Detective Norman Rayford, Kevin Richard Griffith, 35, 200 blocks from Central Avenue, was arrested Saturday on a felony 6 warrant for breach of duty of a dangerous communicable disease to warn the person at risk. He was released Monday on his own recognizance.

According to an initial report filed by Officer Nathan Smith before he assigned the case to Rayford, Smith was sent to the first block of South Drive on March 24, 2020, where paramedics were called to a report of a woman with difficulty in breathing.

The woman said she had a panic attack after learning that, unbeknownst to her, her boyfriend of two months knew he was HIV-positive and had unprotected sex with her.

At that time, Griffith refused to speak with Smith after his Miranda rights were read, “saying he didn’t understand and just needed a ‘breath’.”

The woman reported that she and Griffith had been drinking when she looked at the nightstand and saw a pill.

“She asked him what it was and he said it was a vitamin,” the report said.

The woman told police she had looked for the pill but could not tell what it was.

“Soon after, she said that (Griffith) was very upset and told him he had lied to her and would tell her the truth,” the report said. “At that time Kevin explained to (the woman) that he had contracted HIV/AIDS in 2016.”

The woman told Smith that before she had unprotected sex with Griffith, she asked him if he had been tested for sexually transmitted diseases. He reportedly replied that when he was released from prison, he had been tested and that he had no disease that he knew of.

It is unclear when and why Griffith was in prison.

The woman had also given Constable Smith a bottle of pills stating it was for Triumeq, which she believed to be the pill she had found.

Triumeq is a three-ingredient drug used to decrease the amount of HIV in the system, which reduces the risk of complications, such as infections or cancer. According to the GoodRX website, studies have shown that up to 88% of people who talk about Triumeq have undetectable HIV viral loads within 48 weeks.

However, in a March 25, 2020 Facebook post, Griffith admitted to being HIV-positive, according to the report.

“I didn’t tell a lot of people and the people I should have told didn’t,” Griffith said. “I met someone and didn’t tell them I was HIV positive. Now I hurt her in her family.

According to the report, officials from Aspire, a community health agency, confirmed that Griffith tested positive on August 31, 2016 at the Muncie site and was notified of the infection.

After being explained his obligations under state law, Griffith also signed an HIV care coordination bond to warn on Dec. 9, 2019, according to the police report. He is obligated to explain his status to needle-sharing partners and sexual partners for both safe and unprotected sex, according to the law and the form he has signed.

Follow Rebecca R. Bibbs on Twitter at @RebeccaB_THB, or call 765-640-4883.

Opening of New Jersey medical practice designed to accommodate members of the LGBTQ community Mon, 27 Jun 2022 14:17:21 +0000

A medical office opens today in New Jersey, intended to welcome members of the LGBTQ community.

Virtua Health is launching Pride Primary Care in Marlton, something personal for doctors like Shanin Gross.

“Right now the LGBTQ community is feeling very tense,” Gross says.

They hope that such a practice will help them.

“Having a practice that is affirming and safe and celebrates you as a person and not just as a patient,” Gross says.

Make it more likely that a person will be engaged in their health care. The focus is on care that affirms a person’s gender identity – HIV testing, treatment and other general needs. For some, it fills a void.

“Usually we have to cross the bridge or search in urban areas, but for those of us in our suburban communities to have a pride organization and practice like this in our own backyard, it’s fine. really far,” said Shane Lipscomb, of Medford.

He says he was taking a drug that helps prevent HIV. Doctors aren’t always well informed, but this time it’s different.

“You are with these doctors, Dr Gross, Dr Levine – who have had the same experiences similar to you who can recognize that.”

They say it’s part of a cultural shift in South Jersey.

The elimination of HCV by 2030 requires an “intensification, a simplification” of care pathways Sat, 25 Jun 2022 15:04:32 +0000



Easterbrook P. EASL-CDC-WHO Symposium: Innovations in Hepatitis Elimination and Launch of WHO HCV Guidelines on Simplified Service Delivery and Diagnosis. Presented at: International Liver Congress; June 22-26, 2022; London (hybrid meeting).

Disclosures: Easterbrook did not report any relevant financial information.

We have not been able to process your request. Please try again later. If you continue to have this problem, please contact

LONDON – WHO presented updated guidelines on hepatitis C, calling for drastic simplification of care pathways to alleviate gaps in access to HCV testing and treatment, at a joint WHO-EASL-symposium CDC at the International Liver Congress.

“In 2016, when the WHO launched its global strategy, there were ambitious plans for elimination, defined as a 90% reduction in incidence and a 65% reduction in mortality,” Philippa Easterbrook, MD, principal investigator of the global programs on HIV, hepatitis and STIs at WHO headquarters in Geneva, told participants. “These could be delivered through the scaling up of six synergistic interventions, including testing and treatment, to achieve elimination by 2030: 90% of those infected diagnosed and 80% of those diagnosed treated. ”

Panel ILC 2022
“If we are to achieve elimination goals, there needs to be a substantial intensification and simplification of care pathways,” Philippa Easterbrook, MD, told the participants. Photocredit: Steve Forrest/EASL

She added: “While excellent progress has been made in many champion countries and more than 10 million people have been treated, according to the WHO World Hepatitis Report a year ago , only 21% of those infected have been diagnosed and 13% treated.. If we are to achieve elimination goals, there needs to be a substantial intensification and simplification of care pathways.

Among its early recommendations, the updated WHO guidelines called for decentralization, integration and task shifting in HCV care. Specifically, WHO has recommended moving HCV treatment and care out of specialist clinics to more peripheral or community-based health facilities where trained non-specialist physicians and nurses can be tasked with patient care to expand outreach. access.

Philippa Easterbrook

“We recommend providing hepatitis C testing and treatment at peripheral or community health facilities, ideally at the same site to increase access to diagnosis, care and treatment,” Easterbrook said. “These facilities can include primary care, harm reduction sites, prisons, HIV clinics, as well as community organizations. We recommend the integration of hepatitis screening and treatment into the existing services of these health facilities. »

The WHO made this a strong recommendation, based on moderate certainty of evidence, other than for the general population where there was less data. The rationale for these recommendations was based on a 2021 evidence review of 142 studies from 33 countries – 14% of which were low- or middle-income countries – that compared full versus partial or no decentralization or integration, as well as the distribution of tasks to non-specialists versus specialists.

In its second updated guidelines, WHO made several conditional recommendations on the use of point-of-care HCV viral load RNA testing, namely that it can be used as an alternative approach to testing of HCV RNA nucleic acid in the laboratory to diagnose HCV viraemic infection. . Additionally, point-of-care HCV RNA testing with a detection limit comparable to laboratory testing can be used as an alternative approach as a test for cure, according to WHO recommendations.

“The rationale for this was based on a review of the evidence from 45 studies involving 27,364 patients, in which 50% of the studies were from low- and middle-income countries, which compared point-of-care viral load with laboratory tests “, Easterbrook noted. “The main message here was that there were better outcomes with point-of-care testing, with a short turnaround time from antibody testing to the start of treatment, increased uptake of burden viral infection and an increase in the absorption of the treatment. The diagnostic performance in terms of sensitivity and specificity compared to laboratory tests was also very high.

Additional advantages of point-of-care HCV RNA testing include its use in lower-level healthcare facilities close to where patients receive care, as well as the ability to integrate with other molecular platforms. at the point of care for diseases such as HIV, TB and COVID-19[FEMININE

Enfin, les directives de l’OMS recommandaient fortement l’utilisation de schémas thérapeutiques antiviraux à action directe pangénotypiques pour tous les adultes, adolescents et enfants âgés de plus de 6 ans atteints de VHC chronique, quel que soit le stade de la maladie. Les enfants âgés de 3 à 5 ans ont reçu une recommandation conditionnelle, basée sur une très faible certitude des preuves.

De plus, pour les schémas thérapeutiques antiviraux à action directe, l’OMS a fortement recommandé l’utilisation du sofosbuvir/daclatasvir, du sofosbuvir/velpatasvir et du glécaprévir/pibrentasvir chez les adolescents et les enfants plus âgés, tandis que les enfants âgés de 3 à 5 ans ont de nouveau reçu une recommandation conditionnelle.

“La justification était basée sur une revue systématique de 49 études chez les adolescents, les enfants plus âgés et les enfants plus jeunes, avec [sustained virologic response] rate of at least 95% in all age groups in all plans,” Easterbrook said. “Serious adverse events and treatment discontinuations were rare and, of course, [the benefit of earlier treatment] is to achieve a cure before the onset of disease progression and in associated liver damage.

]]> Views: Racism in maternity care still exists; Steps to follow before the next pandemic Thu, 23 Jun 2022 13:00:02 +0000

Editorial writers work on these public health topics.

The New York Times: Black maternal mortality is still a crisis

As I prepared to interview Linda Villarosa, the author of a new book, “Under the Skin: The Hidden Toll of Racism on American Lives and on the Health of Our Nation,” I saw a title that reinforced the urgency of the message of his book. “CDC: Disparities in maternal mortality have worsened. The story, from Axios, showed in striking graphs how the gap in maternal mortality between black mothers and mothers of other races has only widened since 2018. In 2020, the year the most recent for which we have data, the maternal mortality rate per 100,000 births was 55.3 for black women, 19.1 for white women, and 18.2 for Hispanic women. (Jessica Grose, 6/22)

Stat: Create an external advisory group to prepare for the next pandemic

As the United States reels from more than one million reported deaths directly from the Covid-19 pandemic, another infectious disease – monkeypox – is beginning to spread. Cases of monkeypox, which scientists have been warning about for years, continue to rise around the world. Covid-19 followed by monkeypox provides an opportunity to reflect on what can be done to reduce the impact of this pandemic and future ones. (Julie L. Swann, 6/23)

Houston Chronicle: Memorial Hermann treated 140 children for gunshots in one year. Here’s what we’re doing about it

One hundred and forty. This is the number of children 18 and under who have been treated for gunshot wounds at Children’s Memorial Hermann Hospital in the past 12 months, an increase of nearly 75% from just three years ago year. With so many unspeakable tragedies unfolding across our country in recent weeks, we can all agree that Americans shouldn’t have to worry about being shot in their grocery store, church, school, doctor’s office, or Anywhere else. We mourn the loss of life, pray and promise “never again”, but we get stuck on the how. You’ve heard it said before, but it bears repeating: gun violence is not a political problem. It is a national public health emergency. And it’s time we started treating it as such. (David L. Callender and James J. McCarthy, 6/23)

Dallas Morning News: Suicide prevention needs a boost from Dallas-area colleges

In the Dallas area, college-aged adults commit suicide more often than people in any other age group, by far. It’s heartbreaking to count the numbers: More than 250 people in their twenties have died by suicide in Dallas County in the past four years, according to the North Texas Behavioral Health Authority. The reasons why people consider suicide are complex, but mental health experts point to economic, housing and social instability as the main reasons young adults are feeling increasingly hopeless. (23/06)

Stat: Congress: Fund PrEP to end the HIV epidemic

As the House Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies considers programs to be funded in the 2023 Budget this week, many public health issues will demand their attention. . A funding decision that aims to end HIV—and that goal can be achieved—would also have long-term benefits for the entire health care system. HIV continues to infect thousands of Americans each year, many of them gay men, even though an effective prevention tool known as pre-exposure prophylaxis (PrEP) is available. PrEP, which reduces the risk of contracting HIV by 99%, was first approved by the FDA in 2012 as a daily pill and is now available in a superior form as a bimonthly injection. (Carl Schmid, 6/22)

Stat: Needed: A clearer explanation of the importance of diversity in clinical trials

Increasing the diversity of participants in clinical trials is all the rage these days. The numbers tell the story: According to data from the Food and Drug Administration, in 2020, 75% of trial participants were white, 11% were Hispanic, 8% were black, and 6% were Asian. Given these numbers, regulators and sponsors are trying to expand the recruitment of people from different racial and ethnic groups. But one thing is missing: a clear explanation of why it matters. (Arthur L. Caplan, 6/23)

The CT Mirror: Back To Basics: New program to help more people in Connecticut access primary care

Studies have shown that people who have a relationship with a trusted primary care provider are more likely to be more satisfied with the healthcare system and are less likely to need emergency care or hospitalization for care. treble. Simply put: when people have what they need to get to their annual medical checkup with a doctor they trust, our communities become healthier and we spend less on health care – two priorities for us in the Connecticut. (Dr. Michael Jefferson, 6/23)

This is part of the KHN Morning Briefing, a summary of health policy coverage by major news outlets. Sign up for an email subscription.
]]> Frier Levitt Obtains Arbitration Award Against Caremark Arising From Improper DIR Charges Tue, 21 Jun 2022 18:15:00 +0000

PBMs assess DIR fees against pharmacies participating in the Medicare Part D networks. any source after the point of sale that offsets PDP costs. In many cases, PBMs unilaterally collect DIR fees from vendors months after the vendor was originally paid by the PBM.

Mission Wellness is minority and female owned San Francisco specialized pharmacy. Due to Caremark’s DIR fees, Mission Wellness was losing money participating in Caremark’s Medicare Part D networks. Caremark and SilverScript benefited at the expense of Mission Wellness, HIV-positive patients and Medicare. Only Mission Wellness’ sheer dedication to the HIV community has motivated them to continue serving HIV patients at a loss. Mission Wellness is one of the few specialty pharmacies located within walking distance of its San Francisco piece. If Mission Wellness had abandoned Caremark’s Medicare network, HIV-positive patients would have suffered. Mission Wellness continued to care for Caremark’s Medicare patient population while facing financial ruin. The owner is passionate about caring for this vulnerable patient population that the Centers for Medicare & Medicaid Services (“CMS”) legally recognizes as one of the few “protected classes” of patients at the federal level. Medicare Part D is our government prescription drug program for people age 65 or older, but HIV-positive patients are eligible for Medicare regardless of age. The care of HIV patients is an issue of national importance, according to CMS and Mission Wellness. But, for Caremark, it’s all about DIR fees.

Caremark has refused to provide the required discovery throughout the arbitration, including the discovery necessary to “verify” Caremark’s medication adherence calculations, which forms the basis of its DIR fee recovery. Even after being sanctioned by the arbitrator, Caremark refused to provide the basis for the DIR methodology.

The victory over Caremark and SilverScript gives hope to independent pharmacies who want to challenge PBM DIR fees. The victory comes almost simultaneously with last week’s announcement that the FTC is currently investigating the practices of Caremark and other PBMs, regarding their improper collection of DIR fees from independent pharmacies. According to trial attorney, co-founding member Jonathan E. Levitt, Esq., “Performance-based DIR fees are a threat to the existence of independent pharmacies and the deleterious impact of DIR fees is felt by patients, Medicare, drug manufacturers, and wholesalers. PBMs benefit from DIR fees.” Levitt concludes that: “Specialty pharmacies should be aware that they have rights under federal law, which may be justified in court.”

About Frier Levitt LLC

Frier Levitt LLC is a leading boutique law firm with offices in New York and New Jersey. The firm’s attorneys are leading practitioners who provide a range of services to healthcare and life sciences clients nationwide. Frier Levitt serves the supplier community, wholesalers, manufacturers and plan sponsors, large medical practices, hospitals, hospital medical staff, ambulatory surgery centers and laboratory companies. For more than 20 years, the Firm has been and continues to be a leader in matters of PBM contracts and applicable law. The firm’s attorneys are at the forefront of challenging the DIR fees imposed by PBM and have successfully challenged the DIR fees against leading PBMs, obtaining more than $40 million in damages on behalf of its pharmacy customers arising from lawsuits and settlements. For more information, please visit

SOURCE Frier & Levitt LLC

The hearing aid conversation that needs to happen Sun, 19 Jun 2022 23:01:30 +0000

Review Editor Rating: Star Tribune Opinion publishes a mix of national and local news comments online and in print every day. To contribute, click here.


“It’s the economy, you idiot!”

Before it became a pop culture reference, this 1992 line from Democratic strategist James Carville was an important reminder to Bill Clinton’s campaign staff: Keep it simple, stick to the facts, and stay focused on what matters.

Thirty years later, hearing aids have become a political punching bag. As in 1992, no one is asking the right questions about hearing health.

In 2017, Congress created a new class of hearing aids for sale in pharmacies for people with perceived mild to moderate hearing loss. Last fall, the Food and Drug Administration released proposed rules for these devices that address everything from sound limits to labeling. During the public comment period that followed, the FDA was overwhelmed with concerns from health organizations, countless hearing care professionals, and nearly every state attorney general. Almost all said, as noted, that these devices could potentially do more harm than good. Until the FDA releases the final rules that will send over-the-counter devices to market, we need to consider how we got here.

The root of the confusion around hearing aids, and the point that needs to be addressed to open up even more access to care, is not the cost; it is skill and care. For three decades, consumer electronics companies have repeated a line: A hearing aid is a consumer electronic device, and manufacturers are overcharging people. These companies think the device is the “solution”, regardless of the role of the hearing care professional. A hearing aid is a piece of the puzzle that must include expert care to ensure patient safety and satisfaction.

Since hearing aids have become part of a political debate, let’s look at the hearing care process as a presidential campaign. Party nomination is like hearing assessment, hearing impairment like a candidate. No two are the same and it takes time to sort out the differences. The assessment determines the type of loss suffered by a person. Then the presidential debates begin. Although choosing a hearing aid is not as controversial as a debate, it is a process. Just as a debate gives clarity to voters, the patient needs to understand how the device can help. A patient’s unique hearing loss and lifestyle are taken into consideration when choosing the device. Everything falls into place on election day. The patient begins to feel results during the fitting, but this is not the last stage. The purchase of this medical device includes professional care for the life of the hearing aid – fittings, follow-up appointments, cleanings and device warranties. The purchase is not the finish line but the starting point.

This bundled approach that includes hearing care professional care is often what Washington overlooks and consumer electronics companies reject. For 30 years, these companies have dipped their toes into the hearing industry, quickly learning that a hearing aid is not a commodity. The idea of ​​offering returns and ongoing service, with wafer-thin margins, drives most businesses to pack their bags. They want to sell a product and move on. They believe that the same business model for headphones and earbuds can be replicated for the sale of a medical device. When hearing health is an integral part of life, the process cannot be so simple.

Since 2014, Bose has said it has a solution, telling consumers and lawmakers that manufacturers are overcharging people. After years of lobbying Congress to create an over-the-counter category, Bose shut down its hearing division just as the FDA is expected to issue OTC regulations. Like Zenith, 3M, Sony, Panasonic, Philips, Bausch and Lomb and Johnson and Johnson, Bose left this industry as quickly as it entered it. There is one element that these companies continue to neglect: care. Patients need more than a do-it-yourself approach to hearing health.

While it’s easy to dismiss the Bose news as a business decision, we have to wonder why that argument is good enough. Bose has changed the hearing industry, and it’s a change I welcome. If OTC hearing aids even help a hard of hearing, that’s a good thing. While I join many professional organizations, state attorneys general, and hearing professionals across the country in their concern about upcoming OTC regulations, I believe that if OTC hearing aids have the proper safeguards to protect patient safety and satisfaction, they could be a valuable addition to the market. However, the simplistic view of “experts” outside the hearing industry cannot confuse, damage the reputation of the hearing aid, or downplay the importance of hearing care professionals.

I hope Bose’s sudden departure will mark a turning point in the conversation around over-the-counter hearing aids – a conversation that should finally focus on the patient, not the profit.

It’s not just a matter of cost; it’s about care. It’s so simple. Hearing is essential, and hearing loss should not be a political slogan. Ignoring the importance of medical device technology and the role of the hearing care professional is not in the best interest of the patient. It’s time for consumer electronics companies and Washington to focus on what matters.

Brandon Sawalich is President and CEO of Starkey, a hearing aid manufacturer based in Eden Prairie. On Twitter: @BrandonSawalich.

South Dallas group brings healthcare resources to June 19 celebrations Fri, 17 Jun 2022 15:00:00 +0000

Along Martin Luther King Jr. Boulevard in South Dallas is Abounding Prosperity, a center dedicated to addressing health and social disparities affecting the black community.

Kirk Myers, Founder and CEO, explains that part of that job is meeting people where they are.

For nearly two decades, he and his team have worked to integrate resources like vaccinations and HIV testing at events like Juneteenth Unity Weekend.

“We’ve had vaccine tickets, so it’s all these different things that have evolved around socialization and how people socialize,” Myers said, “but also peppering it with things that people have needed for good health and good health outcomes.”

June 19, now a federal holiday, commemorates the end of slavery in the United States. It comes as many people are celebrating Pride Month.

Activist Betty Neal has been an advocate for Dallas’ LGBTQ community since the ’70s. She says inclusive spaces like Juneteenth Unity Weekend can serve as teachable moments.

“In this place, with these kids, there is a lesson to be learned about supporting each other, our own time and our communities as black and gay people,” Neal said.

Neal says that within the queer community, it’s important to have black spaces. She remembers living through the height of the AIDS epidemic in Dallas. She says that at that time, drag performers were among the only black people allowed in some queer establishments.

“They need to fundraise for funerals and burials and stuff like that,” she said. “Who are they for? The drag community… So drag has become a vital part of success in the black gay community because of their talent, their ability to reach out and fundraise.”

Growing up in the South Dallas neighborhood of Oak Cliff, Kirk Myers says he didn’t always feel welcome in some of the city’s queer spaces.

“I’m the age where I remember, you know, going to the strip and someone who looked like me would be asked for multiple pieces of ID,” Myers said. “And so it wasn’t really unified at the time.”

Myers says creating more racial unity in the queer community takes work. He says making health care more accessible is a key way to address racial disparities.

Between dance competitions and musical performances, he hopes Juneteenth Unity Weekend will draw people to the healthcare resources Abounding Prosperity has to offer.

“You know, those are hard-fought wins,” he said. “We can all co-exist, and we exist around the things that bind us, not the things that divide us.”

Do you have any advice? Email Solomon Wilson at You can follow Solomon on Twitter @SolomonSeesIt.

KERA News is made possible through the generosity of our members. If you find these reports helpful, consider making a tax-deductible donation today. Thanks.

Medical Matters Weekly welcomes the president of the American Academy of Family Physicians Thu, 16 Jun 2022 01:09:29 +0000

Vermont Business Magazine Ada D. Stewart, MD, FAAFP, is the chair of the board of trustees of the American Academy of Family Physicians and the next guest on Weekly Medical Questions. Viewers are invited to tune in at 12 p.m. on Wednesday, June 22.

The show is produced by Southwestern Vermont Health Care (SVHC) with cooperation from Catamount Access Television (CAT-TV). Viewers can see Weekly Medical Questions at and The show is also available to view or download as a podcast at

Since 2012, Stewart has been a family physician at Cooperative Health in Columbia, SC, as a primary provider and HIV specialist. From 2003 to 2012, Stewart served as chief medical officer and HIV specialist at the Richland Community Health Care Association in Eastover and Columbia, South Carolina. In the aftermath of September 11, 2001, Stewart enlisted in the US Army Reserves, where she continues to serve and rose to the rank of Colonel.

In addition to his national role with the AAFP, Stewart has held numerous leadership positions nationally and locally, including for the South Carolina Academy of Family Physicians. Among many accolades, she was appointed to the Presidential Advisory Council on HIV/AIDS in 2019 and still serves on that council.

Stewart earned her bachelor’s degree in pharmacy from Ohio Northern University in Ada, Ohio, and her medical degree from the Medical College of Ohio. She completed her family medicine residency at Palmetto Richland Memorial Hospital in Columbia, South Carolina. Stewart also has additional certification in HIV care from the American Academy of HIV Medicine and is certified as a Hospice Medical Director by the Hospice Medical Director Certification Board.

The AAFP represents 127,600 physicians and medical students nationwide and advocates on behalf of family physicians and patients to inspire positive change in America’s healthcare system.

Weekly Medical Questions showcases the innovators who are driving positive change in health care and related professions. The show covers all aspects of creating and sustaining a healthy lifestyle for all, including food and nutrition, housing, diversity and inclusion, breakthrough medical care, exercise , mental health, environment, research and government. The show is broadcast on Facebook Live, YouTube and all podcast platforms.

After the program, the video is available on public-access television stations in the region CAT-TV (Comcast channel 1075) and GNAT-TV (Comcast channel 1074), as well as on public-access stations across the United States.

About SVHCs:
Southwestern Vermont Health Care (SVHC) is a preeminent, comprehensive health care system that provides exceptional, convenient, and affordable care to communities in Bennington and Windham counties in Vermont, east of Rensselaer and Washington counties in New York and north of Berkshire County in Massachusetts. The SVHC includes the Southwestern Vermont Medical Center (SVMC), the Southwestern Vermont Regional Cancer Center, the Centers for Living and Rehabilitation, and the SVHC Foundation. SVMC includes 25 primary and specialty care practices.

Southwest Vermont Health Care is one of the most popular small rural health systems in the country. He is the recipient of the American Hospital Association’s 2020 Rural Hospital Leadership Award. Additionally, SVMC was ranked fourth nationally for the value of care it provides by the Lown Institute Hospital Index in 2020 and has received five-time Magnet® recognition from the American Nurses Credentialing Center for l excellence in nursing. The healthcare system is fortunate to have the support of platinum-level corporate sponsor Mack, a leading provider of contract manufacturing services and plastic injection molded parts based in Arlington, VT.

BENNINGTON, VT—June 14, 2022—Southwestern Vermont Medical Center

South Africa could be among the last to roll out child-friendly dolutegravir Tue, 14 Jun 2022 09:00:13 +0000

South Africa may be the last country in Africa to gain access to pediatric formulations of the antiretroviral drug dolutegravir as regulatory delays continue.

In 2019, South Africa introduced guidelines recommending treatment with dolutegravir for adults and children around six years and older, based on weight.

Three years later, however, the country still has not provided widespread access to dispersible and child-friendly formulations. Instead, doctors had to request access on a case-by-case basis. The country’s regulatory body, the South African Health Products Regulatory Authority (SAHPRA), must approve all drugs for use before they can be used in the country.



With respect to drugs, a drug manufactured and sold without a brand name, in situations where the original manufacturer’s patent has expired or is not enforced. Generic drugs contain the same active ingredients as brand name drugs and are comparable in strength, safety, effectiveness, and quality.

tracking loss

In a research study, participants who drop out before the end of the study. In routine clinical care, patients who do not show up for medical appointments and cannot be contacted.


How well something works (in a research study). See also “efficiency”.


Physical form in which a drug is manufactured or administered. Examples of formulations include tablets, capsules, powders, and oral and injectable solutions. A drug can be available in several formulations.

Although the recent SAHPRA approvals pave the way for generic manufacturers to start supplying the drug, they are not yet allowed to do so. The South African Department of Health is currently updating its treatment guidelines to ensure that where generic versions are available, they can be used even in very young children.

Clinicians say the rollout of dispersible dolutegravir is key to making HIV treatment once a day for South African children and improving outcomes. The change comes as some doctors report an increase in sight loss and malnutrition in children living with HIV.

“As clinicians, we want to make sure we have access to these drugs as quickly as possible,” says Moherndran Archary, a professor at the University of KwaZulu-Natal who specializes in pediatric infectious diseases. “As it stands, South Africa will probably be the last country in Africa to have access, and we are the largest supplier of pediatric antiretroviral drugs.”

Dispersible medications can be mixed with liquids such as water or juice. These formulations are crucial for children who may be too old for infant antiretroviral syrups but too young to swallow adult-size tablets. Without many dispersible antiretrovirals, children like this depend on large volumes of syrup several times a day.

Today, the non-profit organization Drugs for Neglected Diseases Initiative (DNDi) announced that SAHPRA has granted accelerated approval to a dispersible four-in-one combination of antiretrovirals abacavir, lamivudine, lopinavir and ritonavir for young people children living with HIV. Produced by pharmaceutical company Cipla, this sweet-tasting combination treat can be mixed into milk or water or sprinkled on foods such as porridge.

South Africa should also see increased access to a dispersible two-in-one of abacavir and lamivudine, which – if it could be combined with similarly formulated dolutegravir – would mean many children would finally be on treatment. once a day.

Around 300,000 children under the age of 15 are living with HIV in South Africa, according to 2021 government data. Just under half of these HIV-positive children are on treatment, and a similar percentage are virally suppressed – figures well lower than those seen in adults.

Patients rely on clinical access programs despite regulatory delays

Other African countries have introduced child-friendly dolutegravir faster, Archary says, as many are accepting World Health Organization (WHO) approval, also known as pre-qualification.

But South Africa requires drugs to be registered by SAHPRA and as part of this it needs companies that invent drugs to register products before generic applications can be processed, says Andy Gray, senior lecturer in pharmacology at the University of KwaZulu-Natal.

Gray explains that regulators like SAHPRA often depend on innovator companies — in the case of pediatric dolutegravir, ViiV Healthcare — to provide baseline data on a drug’s safety and effectiveness, even if they don’t have the intention to market a medicine in the country. Then, generic manufacturers must show that they meet these same standards.

SAHPRA approved ViiV Healthcare’s application on April 29. The drug regulator said it was reviewing two generic applications for pediatric dolutegravir, but did not say which companies made the applications. Still, two generic makers Mylan Laboratories and Macleods Pharmaceuticals hold voluntary licenses to manufacture and sell the drug, ViiV Healthcare spokesman Thomas Jenkins said.

Since 2018, ViiV Healthcare has partnered with the international non-profit organization Clinton Health Access Initiative (CHAI) and drug funding mechanism Unitaid to provide technical support to Mylan and Macleods to produce dolutegravir for children .

“We believe that through these partnerships, we will be able to enable greater access to dispersible dolutegravir 5mg for those who need it most and therefore do not plan to market the product in South Africa at this time,” said Jenkins.

He adds that ViiV Healthcare is supplying certain pediatric medicines on a patient-by-patient basis in South Africa under clinical access programs until generics can be registered.

Several measures underway to improve access to pediatric HIV treatment

Archary and other infectious disease experts from the Southern African HIV Clinicians Society released new guidelines on antiretroviral therapy in May. The society includes many leading HIV experts and periodically reviews the latest scientific evidence to make treatment recommendations. Their guidelines have consistently been adopted as best practice in the private sector in the region and have been a precursor to policy changes in the public sector, particularly in South Africa.

If adopted in South Africa, the company’s advice would allow almost all children around six years of age or older to be switched to an abacavir/lamivudine/dolutegravir regimen based on their weight. For many, this means taking dolutegravir in place of efavirenz or lopinavir/ritonavir in their current regimens. The shift in focus is based in part on inferences drawn from adult data generated by the NADIA and ARTIST studies that showed that lamivudine could be repurposed between first- and second-line treatment regimens.

Archery adds that this change is also supported by data from the ODYSSEY trial in which dolutegravir regimens outperformed traditional efavirenz or lopinavir/ritonavir combinations in children as young as two years old.

The Southern African HIV Clinicians Society is expected to meet with the South African National Department of Health to discuss potential changes.

“I thought I saw the end of malnutrition and HIV ten years ago”

Meanwhile, the department says it is already preparing to offer dolutegravir to even younger children under the age of six who are not currently eligible for treatment.

Health department experts recently approved the addition of pediatric dolutegravir for use in young children to the country’s list of essential medicines, national health department spokesman Foster Mohale said. Medicines must be on this list before they can be procured in large quantities for the country’s public sector or included in treatment guidelines.

Mohale says the country is currently updating its HIV treatment guidelines to allow broader access to pediatric dolutegravir for very young children in anticipation of the upcoming availability of dispersible formulations.

Currently, the preferred regimen for children approximately under six years of age is abacavir/lamivudine and lopinavir/ritonavir. If South Africa decides to allow younger children to take dolutegravir, these children will be able to substitute dolutegravir for lopinavir/ritonavir.

A move towards more effective and simpler pediatric HIV treatment comes as Archary, who works at a major hospital in the port city of Durban, sees growing numbers of children lost to sight and struggling with hunger. South Africa has been hit hard by COVID-19, which is believed to have killed an estimated 300,000 people, but has also led to widespread job losses and increased hunger. Much of the country around Durban also witnessed deadly flooding in April.

“We are seeing system disruption both from a societal perspective, but also in terms of health care delivery systems,” he says. “There is a lot of movement between [health] centers because of financial difficulties…we find a lot of patients who are lost to the system. »

Archary concludes: “I thought I saw the end of malnutrition and HIV ten years ago. Now it’s something we see much more often.”

Expanding Access to HIV and AIDS Care and Prevention Enshrined in Illinois Law | Health Fri, 10 Jun 2022 16:58:00 +0000

(WSIL) — Legislation removing barriers to accessing HIV and AIDS care and prevention is now in effect in Illinois. HB4430 and HB5549 were signed into law Friday by Governor JB Pritzker.

HB4430 allows pharmacists to dispense both pre- and post-exposure prophylaxis (PrEP and PEP) medications without prior referral from a physician.

The law also specifies that when these services are provided by a pharmacist, the care must be covered and reimbursed by insurance at the same rate as when provided by a doctor. Pharmacists will also receive support and training under the bill to refer patients to other care and support services and for further testing.

PrEP and PEP reduce the risk of HIV transmission by preventing the HIV virus from replicating in the human body. When taken correctly, PrEP has been shown to reduce the risk of contracting HIV by up to 99%.

HB5549 ensures that funding from the African American HIV/AIDS Response Fund will support research centers and resource centers run by representative members of the community.

The law project provides for the African American HIV/AIDS Response Fund to create and maintain at least one Black-led Center of Excellence Biomedical HIV Resource Center for every $3,000,000 of funding available.

According to the CDC, 46% of people living with HIV/AIDS in Illinois are black or African American. However, only 8% of PrEP prescriptions written nationwide each year are for black or African Americans. The Fund, originally established in 2006, is designed to target services to reduce the transmission of HIV/AIDS among African Americans.

“If we want to end the HIV/AIDS epidemic in our state by 2030, we must make preventative care like PrEP and PEP available to all Illinoisans,” said Governor JB Pritzker. “These drugs are incredibly effective at preventing infection and transmission, and they are essential to our mission to get to zero. My Administration knows that these efforts must be equity-focused and proactive to have the greatest impact. That’s why we invest in black communities who are disproportionately affected by HIV/AIDS. I am proud to sign these bills which bring us one step closer to our ultimate goal: zero new transmission of HIV.